Concepedia

Enhanced delivery of α-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders

Janet Hsu, Laura Northrup, Tridib Kumar Bhowmick, Silvia Muro

Nanomedicine Nanotechnology Biology and Medicine · 2011 · 71 citations · 28 references

DOIFull text

Open access

Concepts

References

28

Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)

Steven D. Marlin, Timothy A. Springer · Cell · 1987 · 1.7K citations

, , +13

α-Galactosidase A deficiency. Fabry disease

R J Desnick · Medical Entomology and Zoology · 2001 · 581 citations

, , +5

Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted Carriers

Silvia Muro, Carmen Garnacho, Julie A. Champion et al. · Molecular Therapy · 2008 · 566 citations · Full text

, , +17

Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

Priya S. Kishnani, Paula Goldenberg, Stephanie DeArmey et al. · Molecular Genetics and Metabolism · 2009 · 379 citations

, , +5

A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1

Silvia Muro, Rainer Wiewrodt, Anu Thomas et al. · Journal of Cell Science · 2003 · 301 citations

, , +17